益盛藥業(002566.SZ):擬與青緗投資共同投設益盛漢參(吉林)健康生物
格隆匯11月30日丨益盛藥業(002566.SZ)公佈,公司擬與吉林青緗投資諮詢中心(有限合夥)(“青緗投資”)共同投資設立控股子公司“益盛漢參(吉林)健康生物科技有限公司”(暫定名稱,最終以工商行政管理機關核准的名稱為準)。其中,益盛藥業出資510萬元,佔註冊資本的51%;青緗投資出資490萬元,佔註冊資本的49%。
1、雙方將以漢參健康為平台,優勢互補、資源共享,通過不斷加強與品牌方合作,實現多品類、多品牌、多渠道共同發展的經營模式。 2、漢參健康將以益盛藥業產品為核心,同時通過代運營其他品牌的方式,兼容幷包,實現多元化發展。3、漢參健康的產品策略由總經理負責制定,並在經漢參健康公司董事會審議通過後,由總經理結合年度預算方案和經營計劃組織實施。 4、漢參健康線上渠道的選擇、開拓、維護和運營由總經理負責。漢參系列產品的研發、生產及相關知識的培訓由甲方負責。
此次對外投資設立益盛漢參(吉林)健康生物科技有限公司是基於公司戰略規劃和經營發展的需要,延伸公司的產業鏈,帶動人蔘相關產品的銷售,有利於增強企業的核心競爭力,符合公司的長遠發展戰略。公司擬通過設立控股子公司在增強子公司盈利能力的同時,實現業務的整合和資源的優化配置,有利於完善公司“打造人蔘全產業鏈”的發展戰略,更好的拓展市場空間,提高公司的綜合競爭實力,為公司未來持續發展打下堅實基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.